Design and commissioning of new system for registering congenital heart disease (CHDR)

The first registry program of CHD in Iran was begun in the Iranian city of Isfahan, in 2016, under the title of “The Persian Registry Of cardioVascular diseasE (PROVE/CHD).

The objectives of the PROVE/CHD Registry are as follows: 1) to define the incidence of CHD in the city of Isfahan in 5 outpatient clinics (three private clinics and two university outpatient clinics), 2) to determine the known risk factors of CHD, 3) to enhance the quality of care, and 4) to pilot register patients with CHD and determine problems regarding further national CHD registrations.